Autonomous requirements of the Menkes disease protein in the nervous system

Victoria L. Hodgkinson, Sha Zhu, Yanfang Wang, Erik Ladomersky, Karen Nickelson, Gary A. Weisman, Jaekwon Lee, Jonathan D. Gitlin, Michael J. Petris

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Menkes disease is a fatal neurodegenerative disorder arising from a systemic copper deficiency caused by loss-of-function mutations in a ubiquitously expressed copper transporter, ATP7A. Although this disorder reveals an essential role for copper in the developing human nervous system, the role of ATP7A in the pathogenesis of signs and symptoms in affected patients, including severe mental retardation, ataxia, and excitotoxic seizures, remains unknown. To directly examine the role of ATP7A within the central nervous system, we generated Atp7aNes mice, in which the Atp7a gene was specifically deleted within neural and glial cell precursors without impairing systemic copper homeostasis, and compared these mice with the mottled brindle (mo-br) mutant, a murine model of Menkes disease in which Atp7a is defective in all cells. Whereas mo-br mice displayed neurodegeneration, demyelination, and 100% mortality prior to weaning, the Atp7aNes mice showed none of these phenotypes, exhibiting only mild sensorimotor deficits, increased anxiety, and susceptibility to NMDA-induced seizure. Our results indicate that the pathophysiology of severe neurological signs and symptoms in Menkes disease is the result of copper deficiency within the central nervous system secondary to impaired systemic copper homeostasis and does not arise from an intrinsic lack of ATP7A within the developing brain. Furthermore, the sensorimotor deficits, hypophagia, anxiety, and sensitivity to NMDA-induced seizure in the Atp7aNes mice reveal unique autonomous requirements for ATP7A in the nervous system. Taken together, these data reveal essential roles for copper acquisition in the central nervous system in early development and suggest novel therapeutic approaches in affected patients.

Original languageEnglish (US)
Pages (from-to)660-668
Number of pages9
JournalAmerican Journal of Physiology - Cell Physiology
Volume309
Issue number10
DOIs
StatePublished - Jan 1 2015

Fingerprint

Menkes Kinky Hair Syndrome
Nervous System
Copper
Proteins
Seizures
Central Nervous System
N-Methylaspartate
Signs and Symptoms
Homeostasis
Anxiety
Demyelinating Diseases
Ataxia
Weaning
Neuroglia
Intellectual Disability
Neurodegenerative Diseases
Phenotype
Mutation
Mortality
Brain

Keywords

  • Copper
  • Menkes disease
  • Nervous system
  • Nutrition
  • Transporter

ASJC Scopus subject areas

  • Physiology
  • Cell Biology

Cite this

Hodgkinson, V. L., Zhu, S., Wang, Y., Ladomersky, E., Nickelson, K., Weisman, G. A., ... Petris, M. J. (2015). Autonomous requirements of the Menkes disease protein in the nervous system. American Journal of Physiology - Cell Physiology, 309(10), 660-668. https://doi.org/10.1152/ajpcell.00130.2015

Autonomous requirements of the Menkes disease protein in the nervous system. / Hodgkinson, Victoria L.; Zhu, Sha; Wang, Yanfang; Ladomersky, Erik; Nickelson, Karen; Weisman, Gary A.; Lee, Jaekwon; Gitlin, Jonathan D.; Petris, Michael J.

In: American Journal of Physiology - Cell Physiology, Vol. 309, No. 10, 01.01.2015, p. 660-668.

Research output: Contribution to journalArticle

Hodgkinson, VL, Zhu, S, Wang, Y, Ladomersky, E, Nickelson, K, Weisman, GA, Lee, J, Gitlin, JD & Petris, MJ 2015, 'Autonomous requirements of the Menkes disease protein in the nervous system', American Journal of Physiology - Cell Physiology, vol. 309, no. 10, pp. 660-668. https://doi.org/10.1152/ajpcell.00130.2015
Hodgkinson, Victoria L. ; Zhu, Sha ; Wang, Yanfang ; Ladomersky, Erik ; Nickelson, Karen ; Weisman, Gary A. ; Lee, Jaekwon ; Gitlin, Jonathan D. ; Petris, Michael J. / Autonomous requirements of the Menkes disease protein in the nervous system. In: American Journal of Physiology - Cell Physiology. 2015 ; Vol. 309, No. 10. pp. 660-668.
@article{a54c549622774dedac445449564cb385,
title = "Autonomous requirements of the Menkes disease protein in the nervous system",
abstract = "Menkes disease is a fatal neurodegenerative disorder arising from a systemic copper deficiency caused by loss-of-function mutations in a ubiquitously expressed copper transporter, ATP7A. Although this disorder reveals an essential role for copper in the developing human nervous system, the role of ATP7A in the pathogenesis of signs and symptoms in affected patients, including severe mental retardation, ataxia, and excitotoxic seizures, remains unknown. To directly examine the role of ATP7A within the central nervous system, we generated Atp7aNes mice, in which the Atp7a gene was specifically deleted within neural and glial cell precursors without impairing systemic copper homeostasis, and compared these mice with the mottled brindle (mo-br) mutant, a murine model of Menkes disease in which Atp7a is defective in all cells. Whereas mo-br mice displayed neurodegeneration, demyelination, and 100{\%} mortality prior to weaning, the Atp7aNes mice showed none of these phenotypes, exhibiting only mild sensorimotor deficits, increased anxiety, and susceptibility to NMDA-induced seizure. Our results indicate that the pathophysiology of severe neurological signs and symptoms in Menkes disease is the result of copper deficiency within the central nervous system secondary to impaired systemic copper homeostasis and does not arise from an intrinsic lack of ATP7A within the developing brain. Furthermore, the sensorimotor deficits, hypophagia, anxiety, and sensitivity to NMDA-induced seizure in the Atp7aNes mice reveal unique autonomous requirements for ATP7A in the nervous system. Taken together, these data reveal essential roles for copper acquisition in the central nervous system in early development and suggest novel therapeutic approaches in affected patients.",
keywords = "Copper, Menkes disease, Nervous system, Nutrition, Transporter",
author = "Hodgkinson, {Victoria L.} and Sha Zhu and Yanfang Wang and Erik Ladomersky and Karen Nickelson and Weisman, {Gary A.} and Jaekwon Lee and Gitlin, {Jonathan D.} and Petris, {Michael J.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1152/ajpcell.00130.2015",
language = "English (US)",
volume = "309",
pages = "660--668",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "10",

}

TY - JOUR

T1 - Autonomous requirements of the Menkes disease protein in the nervous system

AU - Hodgkinson, Victoria L.

AU - Zhu, Sha

AU - Wang, Yanfang

AU - Ladomersky, Erik

AU - Nickelson, Karen

AU - Weisman, Gary A.

AU - Lee, Jaekwon

AU - Gitlin, Jonathan D.

AU - Petris, Michael J.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Menkes disease is a fatal neurodegenerative disorder arising from a systemic copper deficiency caused by loss-of-function mutations in a ubiquitously expressed copper transporter, ATP7A. Although this disorder reveals an essential role for copper in the developing human nervous system, the role of ATP7A in the pathogenesis of signs and symptoms in affected patients, including severe mental retardation, ataxia, and excitotoxic seizures, remains unknown. To directly examine the role of ATP7A within the central nervous system, we generated Atp7aNes mice, in which the Atp7a gene was specifically deleted within neural and glial cell precursors without impairing systemic copper homeostasis, and compared these mice with the mottled brindle (mo-br) mutant, a murine model of Menkes disease in which Atp7a is defective in all cells. Whereas mo-br mice displayed neurodegeneration, demyelination, and 100% mortality prior to weaning, the Atp7aNes mice showed none of these phenotypes, exhibiting only mild sensorimotor deficits, increased anxiety, and susceptibility to NMDA-induced seizure. Our results indicate that the pathophysiology of severe neurological signs and symptoms in Menkes disease is the result of copper deficiency within the central nervous system secondary to impaired systemic copper homeostasis and does not arise from an intrinsic lack of ATP7A within the developing brain. Furthermore, the sensorimotor deficits, hypophagia, anxiety, and sensitivity to NMDA-induced seizure in the Atp7aNes mice reveal unique autonomous requirements for ATP7A in the nervous system. Taken together, these data reveal essential roles for copper acquisition in the central nervous system in early development and suggest novel therapeutic approaches in affected patients.

AB - Menkes disease is a fatal neurodegenerative disorder arising from a systemic copper deficiency caused by loss-of-function mutations in a ubiquitously expressed copper transporter, ATP7A. Although this disorder reveals an essential role for copper in the developing human nervous system, the role of ATP7A in the pathogenesis of signs and symptoms in affected patients, including severe mental retardation, ataxia, and excitotoxic seizures, remains unknown. To directly examine the role of ATP7A within the central nervous system, we generated Atp7aNes mice, in which the Atp7a gene was specifically deleted within neural and glial cell precursors without impairing systemic copper homeostasis, and compared these mice with the mottled brindle (mo-br) mutant, a murine model of Menkes disease in which Atp7a is defective in all cells. Whereas mo-br mice displayed neurodegeneration, demyelination, and 100% mortality prior to weaning, the Atp7aNes mice showed none of these phenotypes, exhibiting only mild sensorimotor deficits, increased anxiety, and susceptibility to NMDA-induced seizure. Our results indicate that the pathophysiology of severe neurological signs and symptoms in Menkes disease is the result of copper deficiency within the central nervous system secondary to impaired systemic copper homeostasis and does not arise from an intrinsic lack of ATP7A within the developing brain. Furthermore, the sensorimotor deficits, hypophagia, anxiety, and sensitivity to NMDA-induced seizure in the Atp7aNes mice reveal unique autonomous requirements for ATP7A in the nervous system. Taken together, these data reveal essential roles for copper acquisition in the central nervous system in early development and suggest novel therapeutic approaches in affected patients.

KW - Copper

KW - Menkes disease

KW - Nervous system

KW - Nutrition

KW - Transporter

UR - http://www.scopus.com/inward/record.url?scp=84947229510&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947229510&partnerID=8YFLogxK

U2 - 10.1152/ajpcell.00130.2015

DO - 10.1152/ajpcell.00130.2015

M3 - Article

C2 - 26269458

AN - SCOPUS:84947229510

VL - 309

SP - 660

EP - 668

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 10

ER -